Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.
Journal Information
Full Title: Angiogenesis
Abbreviation: Angiogenesis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors would like to thank Gregory Stoddard for his expert advice in biostatistics and Scott Hammond for his help in using microRNA30 embedded shRNAs originally used with the CD44 promoter. This research was supported by the National Eye Institute Grants EY015130, EY017011 (to M.E.H.), and under Ruth L. Kirschstein National Research Service Award EY024234 (to A.B.S.) and by an Unrestricted Grant from Research to Prevent Blindness (to the Department of Ophthalmology & Visual Sciences). Imaging support was provided by the National Eye Institute Vision Core Grant EY014800. T.K. was supported by National Institutes of Health Grants DK058702 and HL128119."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025